북미의 해부 병리학 시장 보고서(2021-2031년) : 범위, 세분화, 동향, 경쟁 분석

The anatomic pathology market is projected to grow significantly, reaching approximately USD 21,398.45 million by 2031, up from USD 12,692.48 million in 2023. This growth represents a compound annual growth rate (CAGR) of 6.7% from 2023 to 2031.

Executive Summary and North America Anatomic Pathology Market Overview

In North America, the anatomic pathology market is divided into three main regions: the United States, Canada, and Mexico. This region is recognized as a major player in the anatomic pathology sector, primarily due to the increasing incidence of cancer, enhanced government initiatives aimed at cancer screening, a growing emphasis on accurate disease diagnosis, and the rising demand for advanced healthcare systems. Additionally, the market is expected to benefit from heightened research and development activities by key industry players, along with the introduction of new products, which are anticipated to propel the growth of the anatomic pathology market in North America throughout the forecast period.

North America Anatomic Pathology Market Segmentation Analysis

The analysis of the North American anatomic pathology market is based on several key segments, including products and services, applications, and end users.

1. Products and Services: The market is categorized into services, instruments, and consumables. In 2023, instruments accounted for the largest market share. The services segment is further divided into histopathology and cytopathology, while the instruments segment includes microtomes, cryostats, automatic stainers, tissue processors, and other related tools.

2. Applications: The market is segmented by application into disease diagnosis, drug discovery and development, and other areas. The disease diagnosis segment held the largest share in 2023, reflecting the critical role of anatomic pathology in identifying various diseases.

3. End Users: The end-user segmentation includes hospitals, research laboratories, diagnostic laboratories, and others. Hospitals represented the largest share of the market in 2023, highlighting their central role in the delivery of anatomic pathology services.

North America Anatomic Pathology Market Outlook

Companies, both large and small, operating within the anatomic pathology market are increasingly implementing various strategies such as geographic expansion, launching new products, and advancing technology to enhance their revenue streams. Recent developments in the market include:

• May 2024: Quest Diagnostics and PathAI announced a collaboration aimed at accelerating the integration of digital and AI pathology innovations to enhance the quality, speed, and efficiency of cancer and disease diagnoses. As part of this agreement, Quest will acquire specific assets from PathAI Diagnostics, which specializes in digital and anatomic pathology laboratory services.
• April 2024: Medline became the distributor for Epredia, a member of the PHC Group, which offers solutions for precision cancer diagnostics and tissue diagnostics in the anatomic pathology sector. This partnership allows Medline to expand its portfolio of laboratory products and equipment.
• April 2024: StatLab Medical Products acquired Scientific Device Laboratory, a Chicago-based manufacturer of diagnostic slides and consumables for anatomic pathology and microbiology. This acquisition enhances StatLab's manufacturing capabilities and market presence.
• February 2024: Hologic Inc received FDA approval for its Genius Digital Diagnostics System, a cutting-edge digital cytology system designed for pap testing, which is set to launch in the US in 2024 after being available in Europe, Australia, and New Zealand.

These strategic initiatives by market players are expected to significantly contribute to the growth of the anatomic pathology market.

North America Anatomic Pathology Market Country Insights

The North American anatomic pathology market is primarily composed of the US, Canada, and Mexico, with the US holding the largest market share in 2023. Cancer remains a major public health concern in the US, with prevalent types including breast, lung, prostate, colon, and liver cancers. According to the National Cancer Institute, approximately 17.43 million individuals were living with cancer in the US as of 2021, with projections indicating that the number of cancer survivors could reach 22.2 million by 2030. This increasing prevalence of cancer is expected to drive demand for various pathologic diagnostic tests, including biopsies, fine-needle aspirations, genetic testing, and other innovative techniques.

Moreover, the US has witnessed remarkable advancements in medical technologies, leading to the development of sophisticated medical devices within the healthcare sector. Companies in the US anatomic pathology market are focused on creating innovative and user-friendly instruments and consumables for pathological procedures. For instance, in November 2023, Illumina Inc. launched a new version of its liquid biopsy assay, TruSight Oncology 500 ctDNA v2, which allows for comprehensive noninvasive genomic profiling of circulating tumor DNA from blood samples, complementing traditional tissue-based testing. In 2020, F. Hoffmann-La Roche received FDA approval for the expanded use of the CINtec PLUS Cytology test, aiding in cervical cancer prevention.

These factors, including the high cancer prevalence, the presence of major industry players, and the availability of high-quality infrastructure for hospitals and clinical laboratories, are expected to further bolster the growth of the anatomic pathology market in the US.

North America Anatomic Pathology Market Company Profiles

Key players in the North American anatomic pathology market include F. Hoffmann-La Roche Ltd, Beckman Coulter Inc, Hologic Inc, Agilent Technologies Inc, BioGenex Laboratories Inc, Diapath S.p.A., Bio SB, Merck KGaA, and PHC Holdings Corporation, among others. These companies are actively pursuing strategies such as market expansion, product innovation, and mergers and acquisitions to enhance their offerings and increase their market share.

Table Of Contents

1. Introduction

• 1.1 The Insight Partners Research Report Guidance
• 1.2 Market Segmentation

2. Executive Summary

• 2.1 Key Insights

3. Research Methodology

• 3.1 Secondary Research
• 3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America Anatomic Pathology Market Landscape

• 4.1 Overview
• 4.2 PEST Analysis

5. North America Anatomic Pathology Market - Key Market Dynamics

• 5.1 Market Drivers
  • 5.1.1 Increase in Prevalence of Cancer and Kidney Diseases
  • 5.1.2 Rise in Number of Strategic Initiatives
• 5.2 Market Restraints
  • 5.2.1 Lack of Skilled Professionals
• 5.3 Market Opportunities
  • 5.3.1 Growing Focus on Personalized Medicines
• 5.4 Future Trends
  • 5.4.1 Integration of Artificial Intelligence and Machine Learning
• 5.5 Impact of Drivers and Restraints:

6. Anatomic Pathology Market - North America Analysis

• 6.1 North America Anatomic Pathology Market Revenue (US$ Million), 2021-2031
• 6.2 North America Anatomic Pathology Market Forecast Analysis

7. North America Anatomic Pathology Market Analysis - by Product and Services

• 7.1 Services
  • 7.1.1 Overview
  • 7.1.2 Services: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
• 7.2 Instruments
  • 7.2.1 Overview
  • 7.2.2 Instruments: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
• 7.3 Consumables
  • 7.3.1 Overview
  • 7.3.2 Consumables: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)

8. North America Anatomic Pathology Market Analysis - by Application

• 8.1 Disease Diagnosis
  • 8.1.1 Overview
  • 8.1.2 Disease Diagnosis: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
• 8.2 Drug Discovery and Development
  • 8.2.1 Overview
  • 8.2.2 Drug Discovery and Development: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
• 8.3 Others
  • 8.3.1 Overview
  • 8.3.2 Others: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)

9. North America Anatomic Pathology Market Analysis - by End User

• 9.1 Hospitals
  • 9.1.1 Overview
  • 9.1.2 Hospitals: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
• 9.2 Research Laboratories
  • 9.2.1 Overview
  • 9.2.2 Research Laboratories: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
• 9.3 Diagnostic Laboratories
  • 9.3.1 Overview
  • 9.3.2 Diagnostic Laboratories: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
• 9.4 Others
  • 9.4.1 Overview
  • 9.4.2 Others: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)

10. North America Anatomic Pathology Market - Country Analysis

• 10.1 North America
  • 10.1.1 North America Anatomic Pathology Market Overview
  • 10.1.2 North America Anatomic Pathology Market - Revenue and Forecast Analysis - by Country
    • 10.1.2.1 United States: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
      • 10.1.2.1.1 United States: North America Anatomic Pathology Market Breakdown, by Product and Services
        • 10.1.2.1.1.1 United States: North America Anatomic Pathology Market Breakdown, by Services
        • 10.1.2.1.1.2 United States: North America Anatomic Pathology Market Breakdown, by Instruments
      • 10.1.2.1.2 United States: North America Anatomic Pathology Market Breakdown, by Application
      • 10.1.2.1.3 United States: North America Anatomic Pathology Market Breakdown, by End User
    • 10.1.2.2 Canada: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
      • 10.1.2.2.1 Canada: North America Anatomic Pathology Market Breakdown, by Product and Services
        • 10.1.2.2.1.1 Canada: North America Anatomic Pathology Market Breakdown, by Services
        • 10.1.2.2.1.2 Canada: North America Anatomic Pathology Market Breakdown, by Instruments
      • 10.1.2.2.2 Canada: North America Anatomic Pathology Market Breakdown, by Application
      • 10.1.2.2.3 Canada: North America Anatomic Pathology Market Breakdown, by End User
    • 10.1.2.3 Mexico: North America Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
      • 10.1.2.3.1 Mexico: North America Anatomic Pathology Market Breakdown, by Product and Services
        • 10.1.2.3.1.1 Mexico: North America Anatomic Pathology Market Breakdown, by Services
        • 10.1.2.3.1.2 Mexico: North America Anatomic Pathology Market Breakdown, by Instruments
      • 10.1.2.3.2 Mexico: North America Anatomic Pathology Market Breakdown, by Application
      • 10.1.2.3.3 Mexico: North America Anatomic Pathology Market Breakdown, by End User

11. Industry Landscape

• 11.1 Overview
• 11.2 Growth Strategies in North America Anatomic Pathology Market
• 11.3 Organic Growth Strategies
  • 11.3.1 Overview
• 11.4 Inorganic Growth Strategies
  • 11.4.1 Overview

12. Company Profiles

• 12.1 F. Hoffmann-La Roche Ltd
  • 12.1.1 Key Facts
  • 12.1.2 Business Description
  • 12.1.3 Products and Services
  • 12.1.4 Financial Overview
  • 12.1.5 SWOT Analysis
  • 12.1.6 Key Developments
• 12.2 Beckman Coulter Inc
  • 12.2.1 Key Facts
  • 12.2.2 Business Description
  • 12.2.3 Products and Services
  • 12.2.4 Financial Overview
  • 12.2.5 SWOT Analysis
  • 12.2.6 Key Developments
• 12.3 Hologic Inc
  • 12.3.1 Key Facts
  • 12.3.2 Business Description
  • 12.3.3 Products and Services
  • 12.3.4 Financial Overview
  • 12.3.5 SWOT Analysis
  • 12.3.6 Key Developments
• 12.4 Agilent Technologies Inc
  • 12.4.1 Key Facts
  • 12.4.2 Business Description
  • 12.4.3 Products and Services
  • 12.4.4 Financial Overview
  • 12.4.5 SWOT Analysis
  • 12.4.6 Key Developments
• 12.5 BioGenex Laboratories Inc
  • 12.5.1 Key Facts
  • 12.5.2 Business Description
  • 12.5.3 Products and Services
  • 12.5.4 Financial Overview
  • 12.5.5 SWOT Analysis
  • 12.5.6 Key Developments
• 12.6 Diapath S.p.A.
  • 12.6.1 Key Facts
  • 12.6.2 Business Description
  • 12.6.3 Products and Services
  • 12.6.4 Financial Overview
  • 12.6.5 SWOT Analysis
  • 12.6.6 Key Developments
• 12.7 Bio SB
  • 12.7.1 Key Facts
  • 12.7.2 Business Description
  • 12.7.3 Products and Services
  • 12.7.4 Financial Overview
  • 12.7.5 SWOT Analysis
  • 12.7.6 Key Developments
• 12.8 Merck KGaA
  • 12.8.1 Key Facts
  • 12.8.2 Business Description
  • 12.8.3 Products and Services
  • 12.8.4 Financial Overview
  • 12.8.5 SWOT Analysis
  • 12.8.6 Key Developments
• 12.9 PHC Holdings Corporation
  • 12.9.1 Key Facts
  • 12.9.2 Business Description
  • 12.9.3 Products and Services
  • 12.9.4 Financial Overview
  • 12.9.5 SWOT Analysis
  • 12.9.6 Key Developments

13. Appendix

• 13.1 About Us
• 13.2 Glossary of Terms